Clorox director buys 5,000 shares via trust

Clorox director Pierre R. Breber, through a trust, made an open-market purchase of 5,000 shares of Common Stock at a weighted average price of about $85.82 per share.

Rhea-AI Filing Summary

Clorox director Pierre R. Breber, through a trust, made an open-market purchase of 5,000 shares of Common Stock at a weighted average price of about $85.82 per share. Following this transaction, the trust’s indirect holdings increased to 18,000 Clorox shares.

The shares were bought in multiple trades within a price range from $85.19 to $86.01, according to the filing footnote.

Insider Trade Summary

Net Buyer: 5,000 shares

Net Buy 1 txn

Insider Breber Pierre R

Role Director

Bought 5,000 shs ($429K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$85.8248	$429K

Holdings After Transaction: Common Stock — 18,000 shares (Indirect, By Trust)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $85.1900 to $86.0100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares purchased: 5,000 shares Weighted average purchase price: $85.8248 per share Post-transaction holdings: 18,000 shares +1 more

4 metrics

Shares purchased 5,000 shares Open-market purchase by trust on May 5, 2026

Weighted average purchase price $85.8248 per share Average price across multiple trades

Post-transaction holdings 18,000 shares Indirectly held by trust following the transaction

Trade price range $85.19–$86.01 per share Prices at which individual trades were executed

Key Terms

open-market purchase, indirect ownership, weighted average price, Form 4

4 terms

open-market purchase financial

"made an open-market purchase of 5,000 shares of Common Stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"the trust’s indirect holdings increased to 18,000 Clorox shares"

weighted average price financial

"bought 5,000 shares at a weighted average price of about $85.82"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 regulatory

"as disclosed in the transaction footnote in the Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Clorox (CLX) director Pierre R. Breber report?

Director Pierre R. Breber reported an open-market purchase of 5,000 shares of Clorox common stock through a trust. The shares were acquired at a weighted average price of about $85.82 per share, consolidating his indirect ownership position in the company.

At what price did the Clorox (CLX) director’s trust buy the 5,000 shares?

The trust associated with director Pierre R. Breber bought 5,000 Clorox shares at a weighted average price of approximately $85.82. Individual trades were executed across a range from $85.19 to $86.01, as disclosed in the transaction footnote in the Form 4.

How many Clorox (CLX) shares does the Breber-related trust hold after this transaction?

After the reported purchase, the trust associated with director Pierre R. Breber holds 18,000 shares of Clorox common stock indirectly. This post-transaction total reflects the newly acquired 5,000 shares added to the trust’s prior holdings as disclosed in the insider filing.

Is Pierre R. Breber’s Clorox (CLX) share ownership direct or indirect?

The reported 5,000-share purchase and resulting 18,000-share position are held as indirect ownership by a trust. The Form 4 lists the nature of ownership as “By Trust,” meaning the shares are not recorded as directly owned in his personal name.

What does the trading range mean in the Clorox (CLX) director’s Form 4 filing?

The filing notes the transaction occurred in multiple trades between $85.19 and $86.01 per share. The reported $85.82 figure is a weighted average price across those trades, with detailed trade-level information available upon request from the issuer or regulatory staff.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 04:54 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Breber Pierre R

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CALIFORNIA 94612-1888

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/05/2026		P		5,000	A	$85.8248(1)	18,000	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $85.1900 to $86.0100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	By Jinho Joo, Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)